Literature DB >> 2961577

Molecular analysis of the antigen receptor of virus-specific cytotoxic T cells and identification of a new V alpha family.

H Pircher1, E E Michalopoulos, A Iwamoto, P S Ohashi, J Baenziger, H Hengartner, R M Zinkernagel, T W Mak.   

Abstract

We have determined the primary structure of the alpha/beta-antigen receptor of a lymphocytic choriomeningitis virus (LCMV)-specific cytotoxic T cell clone (P14). The beta chain of the T cell receptor is composed of V beta 8.1, D beta and J beta 2.4 gene segments while the alpha chain uses a member of the V alpha 2 family and J alpha TA31. Southern blot analysis of a panel of six other independent LCMV-specific cytotoxic T cell clones did not reveal any preferential usage of the V alpha 2 or V beta 8 gene families in the cytotoxic LCMV response. Additionally, we have isolated and sequenced cDNA clones derived from the non-functionally rearranged alpha allele of P14. This transcript is composed of a unique V alpha gene segment which belongs to a new V alpha gene family.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2961577     DOI: 10.1002/eji.1830171226

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  Cutting edge: persistently open chromatin at effector gene loci in resting memory CD8+ T cells independent of transcriptional status.

Authors:  Valerie P Zediak; Jonathan B Johnnidis; E John Wherry; Shelley L Berger
Journal:  J Immunol       Date:  2011-01-28       Impact factor: 5.422

2.  Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.

Authors:  Y Yanagi; A Tishon; H Lewicki; B A Cubitt; M B Oldstone
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity.

Authors:  M S Horwitz; Y Yanagi; M B Oldstone
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

4.  Characterization of the mouse Tcra-V22 gene subfamily.

Authors:  A K Dattamajumdar; S W Li; D P Jacobson; W Ladiges; L E Hood; G E Osman
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  Perforin is a critical physiologic regulator of T-cell activation.

Authors:  Jennifer E Lykens; Catherine E Terrell; Erin E Zoller; Kimberly Risma; Michael B Jordan
Journal:  Blood       Date:  2011-05-23       Impact factor: 22.113

6.  Derivation of T-cell receptor alpha-chain double expresser lines from normal murine mature T cells.

Authors:  K Eshima; H Suzuki; S Yamazaki; N Shinohara
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

7.  Polymorphism of cytotoxic T-lymphocyte clones that recognize a defined nine-amino-acid immunodominant domain of lymphocytic choriomeningitis virus glycoprotein.

Authors:  E Joly; M Salvato; J L Whitton; M B Oldstone
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

8.  Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.

Authors:  Jinzhu Li; Sarah K Figueira; Alexandra C A Vrazo; Brock F Binkowski; Braeden L Butler; Yasuhiro Tabata; Alexandra Filipovich; Michael B Jordan; Kimberly A Risma
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

9.  Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity.

Authors:  Logan K Smith; Giselle M Boukhaled; Stephanie A Condotta; Sabrina Mazouz; Jenna J Guthmiller; Rahul Vijay; Noah S Butler; Julie Bruneau; Naglaa H Shoukry; Connie M Krawczyk; Martin J Richer
Journal:  Immunity       Date:  2018-01-23       Impact factor: 31.745

10.  Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection.

Authors:  Stephanie A Condotta; Deepa Rai; Britnie R James; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.